irritable bowel syndrome
The CDPath prognostic tool gives Crohn's patients risk scores for serious complications within three years, so they can make more informed treatment decisions.
Genetic Loci With Link to Bowel Movement Frequency May Point to GI Condition Treatments
Individuals with irritable bowel syndrome marked by diarrhea further tended to have higher scores on a polygenic measure of stool frequency.
In particular, the diagnostics company expects the new resource to strengthen its offerings to pharmaceutical partners, a key customer group.
Longitudinal Irritable Bowel Syndrome Omics Study Points to Possible Treatment Target
Using transcriptomic, metabolomic, metagenomic, and other data types, a team identified purine metabolism as a potential target for intervention.
Theradiag to Commercialize PredictImmune IBD Test in French-Speaking Europe and Africa
Under the agreement, Theradiag will promote, license, and distribute PredictImmune's PredictSure IBD test in France, Belgium, Luxembourg, Switzerland, and the Maghreb countries.